Draft a Board-Ready AI Governance Accountability Memo for Hospital Executives

The task

You're a Chief Medical Information Officer, VP of Quality, or Chief AI Officer prepping for a board or executive committee meeting. Leadership wants to know who owns each deployed AI tool, how drift is being monitored, and where the gaps sit — in writing, before the next quality committee.

Before AI

You pull the AI inventory spreadsheet, chase down owners in Slack, cross-reference vendor contracts against your model risk log, and write the memo from scratch in Word. A thorough draft is a half-day of work, and it usually reads like an IT status report instead of a governance document. The STAT commentary from Pronovost, Norden, and Mate argues senior leaders must treat AI governance as their own daily job, not something the technology committee handles quarterly — which means the memo needs to name executives, not just committees.

The workflow

1) Structure the inventory into a governance table. Paste your raw list of deployed AI tools plus known gaps into the first prompt. It normalizes the mess into a table an executive can actually read.

You are helping a hospital CMIO prepare a board-ready AI governance memo. Below is a raw dump of the health system's AI tool inventory and known governance gaps. Do the following:

1. Extract every distinct AI tool or model mentioned and produce a markdown table with these columns: Tool name | Clinical use case | Vendor/Internal | EHR integration point | Current named executive owner (or "UNASSIGNED") | Last performance/drift review date (or "NONE ON RECORD") | Risk tier (High / Medium / Low based on patient-facing impact) | Known governance gap.

2. Below the table, list every tool where the executive owner is UNASSIGNED or the last drift review is NONE ON RECORD. Flag these as "Accountability gaps requiring immediate assignment."

3. Do not invent tools, owners, or dates. If a field is missing from the input, mark it UNASSIGNED or NONE ON RECORD.

Return only the table and the flagged list. No preamble.

INPUT:

AI Tool Inventory — Mercy Ridge Health System (fabricated sample)

- Sepsis Watch (Epic-integrated early warning): deployed 14 months ago in adult ICUs and med-surg. Vendor: Epic Cognitive Compute. Owner listed on intranet: "Clinical Informatics." No drift review since go-live. Concerns raised by ICU nursing about alert fatigue in April.
- RadAssist-CT (radiology triage for intracranial hemorrhage): FDA-cleared, vendor Aidoc-equivalent. Deployed 8 months ago across 4 hospitals. Owner: Dr. A. Reyes, Chief of Radiology. Last vendor performance report received March 2026. No internal validation against Mercy Ridge patient population.
- Ambient scribe (Nuance DAX-equivalent): 1,200 clinician users across primary care and specialty. Deployed 20 months ago. Owner: unclear — IT rolled it out, no clinical exec assigned. HIPAA BAA in place. No accuracy audit performed on generated notes.
- Discharge-summary drafter (internal LLM built on Azure OpenAI): pilot on 3 med-surg units. Owner: Innovation Team (no named exec). Not yet integrated with Epic; clinicians copy-paste. No bias testing done.
- Readmission risk model (internal, built 2022): scores every inpatient nightly, feeds Epic Storyboard. Owner: Population Health analytics director J. Kwon. Last recalibration: 2023. Post-COVID payer mix has shifted significantly.
- Prior-auth response generator (revenue cycle): drafts appeal letters. Owner: RCM director M. Patel. No clinical review of drafted content before sending.

Known gaps flagged by internal audit (June 2026):
- No central AI registry maintained by any single office
- Board has not received an AI performance report in the last 12 months
- No policy on when a drifting model must be paused
- Compliance has not reviewed the ambient scribe's note retention against HIPAA minimum-necessary standard

2) Assign accountability and draft the memo body. Feed the normalized table into a memo generator that names executives by role and writes in the register a board expects.

Using the governance table and gap list you just produced, draft a board-ready memo from the CMIO to the Executive Committee. Follow this structure exactly:

**MEMO**
TO: Executive Committee and Board Quality & Safety Subcommittee
FROM: Chief Medical Information Officer
RE: AI System Accountability and Drift Oversight — Current State and Proposed Owners
DATE: [leave as bracketed placeholder]

**1. Why this memo now (3-4 sentences).** Reference the governance principle that AI oversight is an executive responsibility, not a committee's quarterly agenda item. Note the risk of undetected model drift in clinical tools.

**2. Current state.** Insert the governance table verbatim.

**3. Accountability gaps.** For each UNASSIGNED tool, propose a named executive role that should own it (e.g., "Chief Medical Officer for clinical decision-support tools," "Chief Compliance Officer for documentation AI," "CFO for revenue-cycle AI"). Justify each in one sentence tied to the tool's risk profile.

**4. Drift and monitoring gaps.** List every tool with NONE ON RECORD or stale reviews. For each, specify: (a) what type of monitoring is needed (calibration check, bias audit, clinician override rate, patient outcome tracking), (b) proposed review cadence, (c) the executive who signs off on each review.

**5. Immediate actions requested of the Executive Committee.** A numbered list of 4-6 concrete decisions the committee needs to make at this meeting — e.g., approve named owners, authorize a pause-on-drift policy, fund monitoring infrastructure. Each action should have a target date within 90 days.

**6. What the board will see next quarter.** Two sentences describing the reporting format the CMIO will bring back.

Write in plain executive English. No hype language, no "leverage" or "transform." Under 900 words. Do not invent metrics or outcomes — if a number is not in the input, do not fabricate one.

3) Pressure-test the draft against the three failure modes leadership actually asks about. This step surfaces the questions a skeptical board member will raise so you can pre-empt them.

You are now a skeptical board member with a legal and patient-safety background reviewing the memo above. Produce three sections:

**A. Three questions I will ask at the meeting.** Specific, uncomfortable, tied to named tools in the memo — e.g., "The readmission model has not been recalibrated since 2023. What patients may have been mis-scored, and do we have a duty to notify?"

**B. Weak spots in the accountability assignments.** Where does the memo assign a role without giving that role the authority, budget, or data access to actually own the tool? Name each one.

**C. HIPAA and clinical-liability exposures the memo underplays.** Be specific about which tool creates which exposure (e.g., ambient scribe note retention, LLM-drafted discharge summaries entering the legal medical record, prior-auth letters sent without clinical review).

Return as a short briefing the CMIO can read on the way to the meeting. Bulleted, under 400 words.

4) Merge and finalize. Paste the memo (step 2 output) and the pre-mortem (step 3 output) into your doc. The pre-mortem becomes a private prep sheet; the memo goes to the committee.

Gotchas

• The model will invent owners if your input is vague. If you write "someone in IT owns it," some models will confabulate a name. The step-1 prompt forces UNASSIGNED, but spot-check the table.
• Risk tiering is only as good as your input. A model with no clinical footprint can still be high-risk if it drafts documentation that enters the legal medical record. Review the tier column manually.
• This is not a substitute for your model risk framework. If your system uses a formal framework (e.g., the AMA governance for augmented intelligence toolkit), map the memo's actions back to it before circulating.
• Do not paste real PHI or patient counts you can't verify. The prompts work fine on tool-level metadata; keep it there.
• The "propose an executive owner" step is opinionated. For tools that cross clinical, revenue, and compliance lines (ambient scribes, prior-auth generators), the AI will pick one owner. Your real governance may require dual sign-off.

Time saved

A CMIO or governance lead who normally spends 4-5 hours structuring the inventory, drafting the memo, and anticipating board questions can get a defensible first draft in about 30-45 minutes of prompt work plus review. Conservative estimate: 3-4 hours per memo, most of it recovered on the writing and the pre-mortem. The inventory reconciliation itself still requires you to know your environment — the AI cannot discover tools you forgot to list.

What we got when we ran it

We executed every prompt above, in order, against the sample input (model: claude-sonnet-4-6). Outputs below are real and unedited apart from length truncation.

Step 1 output

Mercy Ridge Health System — AI Tool Inventory | Tool Name | Clinical Use Case | Vendor / Internal | EHR Integration Point | Current Named Executive Owner | Last Performance / Drift Review Date | Risk Tier | Known Governance Gap | |---|---|---|---|---|---|---|---| | Sepsis Watch | Early warning for sepsis in adult ICUs and med-surg | Vendor (Epic Cognitive Compute) | Epic (native integration) | UNASSIGNED ("Clinical Informatics" listed — no named exec) | NONE ON RECORD (no review since go-live ~14 months ago) | High | No drift review since deployment; alert fatigue complaints from ICU nursing (April 2026) not formally adjudicated; no named accountable executive | | RadAssist-CT | Radiology triage for intracranial hemorrhage | Vendor (FDA-cleared; Aidoc-equivalent) | Radiology workflow across 4 hospitals | Dr. A. Reyes, Chief of Radiology | March 2026 (vendor report only) | High | No internal validation against Mercy Ridge patient population; vendor-provided report only — no independent internal performance review | | Ambient Scribe | Automated clinical documentation for 1,200 clinicians across primary care and specialty | Vendor (Nuance DAX-equivalent) | Not specified (clinician-facing; notes enter EHR via clinician review) | UNASSIGNED (IT deployed; no clinical exec assigned) | NONE ON RECORD (no accuracy audit performed) | High | No named clinical executive owner; no accuracy audit of generated notes; Compliance has not reviewed note retention against HIPAA minimum-necessary standard | | Discharge-Summary Drafter | LLM-generated discharge summary drafts on 3 med-surg units (pilot) | Internal (Azure OpenAI)

…output truncated at 250 words.

Step 2 output

MEMO TO: Executive Committee and Board Quality & Safety Subcommittee FROM: Chief Medical Information Officer RE: AI System Accountability and Drift Oversight — Current State and Proposed Owners DATE: [DATE] --- ### 1. Why This Memo Now AI-based clinical tools are operating across this health system today — scoring patients for readmission risk, flagging possible sepsis, and drafting documentation that enters the legal medical record. Accountability for those tools is an executive responsibility, not a standing-committee agenda item, and it requires named owners who can act when a model behaves unexpectedly. Our internal audit completed in June 2026 confirmed that several deployed tools have no named executive owner and have never undergone a formal performance review since go-live. Undetected model drift in clinical settings — where a tool's predictions quietly degrade as the patient population shifts — creates patient safety exposure that this committee is responsible for addressing. --- ### 2. Current State | Tool Name | Clinical Use Case | Vendor / Internal | EHR Integration Point | Current Named Executive Owner | Last Performance / Drift Review Date | Risk Tier | Known Governance Gap | |---|---|---|---|---|---|---|---| | Sepsis Watch | Early warning for sepsis in adult ICUs and med-surg | Vendor (Epic Cognitive Compute) | Epic (native integration) | UNASSIGNED | NONE ON RECORD | High | No drift review since deployment (~14 months); alert fatigue complaints not formally adjudicated; no named accountable executive | | RadAssist-CT | Radiology triage for intracranial hemorrhage | Vendor (FDA-cleared; Aidoc-equivalent)

…output truncated at 250 words.

Step 3 output

Board Member Pre-Meeting Briefing — AI Governance Memo Review --- ### A. Three Questions I Will Ask at the Meeting - **Sepsis Watch has generated no drift review in 14 months and nursing raised alert fatigue concerns in April.** What is our documented response to those April complaints, and if a patient deteriorated during a period of alert fatigue, what does our liability exposure look like today? Who signed off on doing nothing? - **The readmission risk model has scored every inpatient nightly since 2023 without recalibration, against a materially changed patient population.** Can we identify which patients received care decisions influenced by potentially miscalibrated scores? Does our legal counsel believe we have a proactive duty to review those cases, and has Risk Management been consulted? - **The discharge-summary drafter is in active pilot use with no bias testing, no EHR integration, and clinicians copy-pasting AI output directly into the legal medical record.** Who authorized this pilot, under what patient-safety review, and what is the process to pause it today if this committee decides that is appropriate? --- ### B. Weak Spots in the Accountability Assignments - **CMO assigned Sepsis Watch** — the memo gives the CMO sign-off authority but does not allocate budget for an independent validation study, identify who pulls the override-rate data from Epic, or specify what threshold triggers a pause. Ownership without data access and a decision threshold is a title, not control. - **CCO assigned Ambient Scribe** — Compliance can review HIPAA retention risk

…output truncated at 250 words.

---

This content is for informational purposes only and is not medical advice. AI tools used with patient data must meet your organization's HIPAA and privacy requirements.